Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	At The Market Program	Common Stock	Common Stock At The Market Program	Additional Paid-In Capital	Additional Paid-In Capital At The Market Program	Accumulated Deficit	Treasury Stock	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022			74,570,198
Beginning balance at Dec. 31, 2022	$ (323,778)		$ 75		$ 1,071,183		$ (1,340,036)	$ (54,998)	$ (2)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs (in shares)			12,205,000
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs	52,428		$ 12		52,416
Issuance of common stock, net of issuance costs (in shares)				3,312,908
Issuance of common stock, net of issuance costs		$ 4,448		$ 3		$ 4,445
Vesting of restricted stock units (in shares)			1,034,631
Vesting of restricted stock units	1		$ 1
Vesting of ESPP Shares (in shares)			271,084
Vesting of ESPP Shares	740				740
Stock-based compensation	11,958				11,958
Exercise of pre-funded warrants (in shares)			20,965,747
Exercise of pre-funded warrants	21		$ 21
Exercise of warrants (in shares)			5,850,747
Exercise of warrants	$ 8,434		$ 6		8,428
Exercise of stock options (in shares)	0
Other comprehensive gain	$ 2								2
Net loss	(209,248)						(209,248)
Ending balance (in shares) at Dec. 31, 2023			118,210,315
Ending balance at Dec. 31, 2023	(454,994)		$ 118		1,149,170		(1,549,284)	(54,998)	0
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net of issuance costs (in shares)			65,205,000	378,902
Issuance of common stock, net of issuance costs	90,672	513	$ 65	$ 1	90,607	512
Vesting of restricted stock units (in shares)			1,767,857
Vesting of restricted stock units	2		$ 2
Stock-based compensation	11,993				11,993
Exercise of warrants (in shares)			10,272,783
Exercise of warrants	14,808		$ 10		14,798
Exercise of stock options (in shares)			17,606
Exercise of stock options	29				29
Net loss	(51,745)						(51,745)
Ending balance (in shares) at Dec. 31, 2024			195,852,463
Ending balance at Dec. 31, 2024	(388,722)		$ 196		1,267,109		(1,601,029)	(54,998)	0
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net of issuance costs (in shares)			31,065,000	7,661,505
Issuance of common stock, net of issuance costs	72,596	$ 15,408	$ 31	$ 8	72,565	$ 15,400
Vesting of restricted stock units (in shares)			2,627,262
Vesting of restricted stock units	2		$ 2
Vesting of ESPP Shares (in shares)			696,874
Vesting of ESPP Shares	971				971
Stock-based compensation	9,870				9,870
Exercise of warrants (in shares)			7,178,729
Exercise of warrants	$ 10,348		$ 7		10,341
Exercise of stock options (in shares)	89,660		134,310
Exercise of stock options	$ 244		$ 1		243
Net loss	(22,682)						(22,682)
Ending balance (in shares) at Dec. 31, 2025			245,216,143
Ending balance at Dec. 31, 2025	$ (301,965)		$ 245		$ 1,376,499		$ (1,623,711)	$ (54,998)	$ 0